Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of Sativex in MS and neuropathic pain
NCT01606137Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Feb 2002
- Primary completion
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cannabis extract in multiple sclerosis (MS), spasticity, neuropathic pain, pain, sponsored by Jazz Pharmaceuticals plc. Started Feb 2002; status: completed.
02
Drugs
cannabis extract
03
Conditions
multiple sclerosis (MS)spasticityneuropathic painpain
Beyond the preview
Go deeper on NCT01606137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01606137.